Published Guidance, NICE advice and quality standards

Skip to filtersSkip to results

Skip to results

Last updated date

Last updated date

Area of interest

Area of interest

Type

Type

Guidance programme

Advice programme

Showing 1 to 25 of 2346

TitleReference numberPublishedLast updated
Idecabtagene vicleucel for treating relapsed and refractory multiple myeloma after 3 or more treatments (terminated appraisal)TA936
COVID-19 rapid guideline: managing COVID-19NG191
Tisagenlecleucel for treating relapsed or refractory diffuse large B-cell lymphoma after 2 or more systemic therapies (terminated appraisal)TA933
Foslevodopa–foscarbidopa for treating advanced Parkinson's with motor symptomsTA934
Percutaneous thrombectomy for intermediate-risk or high-risk pulmonary embolismIPG778
Decitabine–cedazuridine for untreated acute myeloid leukaemia when intensive chemotherapy is unsuitable (terminated appraisal)TA932
Percutaneous transarterial carotid artery stent placement for asymptomatic extracranial carotid stenosisIPG777
Zanubrutinib for treating chronic lymphocytic leukaemiaTA931
Transient loss of consciousness ('blackouts') in over 16sCG109
Hypertension in adults: diagnosis and managementNG136
Suspected acute respiratory infection in over 16s: assessment at first presentation and initial managementNG237
Biodegradable subacromial spacer insertion for rotator cuff tearsIPG775
Extracorporeal carbon dioxide removal for acute respiratory failureIPG776
Lutetium-177 vipivotide tetraxetan for treating PSMA-positive hormone-relapsed metastatic prostate cancer after 2 or more treatmentsTA930
Virtual reality technologies for treating agoraphobia or agoraphobic avoidance: early value assessmentHTE15
Familial breast cancer: classification, care and managing breast cancer and related risks in people with a family history of breast cancerCG164
Flow transcranial direct current stimulation for treating depressionMIB324
Cabozantinib for previously treated advanced differentiated thyroid cancer unsuitable for or refractory to radioactive iodineTA928
Empagliflozin for treating chronic heart failure with preserved or mildly reduced ejection fractionTA929
Pneumonia in adults: diagnosis and managementCG191
Jaundice in newborn babies under 28 daysCG98
Acute respiratory infection in over 16s: initial assessment and management including virtual wards (hospital at home)QS210
Digital technologies for delivering specialist weight-management services to manage weight-management medicine: early value assessmentHTE14
Ranibizumab for treating diabetic macular oedemaTA274
Daratumumab with lenalidomide and dexamethasone for untreated multiple myeloma when a stem cell transplant is unsuitableTA917

Results per page

  1. 10
  2. 25
  3. 50
  4. All